✦ LIBER ✦

PCN14 PHARMACOECONOMIC ANALYSIS OF TREATING ADVANCED GASTRIC CANCER (AGC) WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN AN ITALIAN SETTING

✍ Scribed by LP Garrison; A Cirrincione; G Giuliani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN104 Cost Minimization Analysis (CMA)

✍ Curescu, S.; Stanculeanu, D.L.; Croitoru, A.; Radu, C.P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN44 COST MINIMIZATION ANALYSIS OF ADVA

✍ P Kawalec; A Szawlowski; I Federowicz; M Szkultecka-Debek; M Russel-Szymczyk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

3519 POSTER Cost of treating advanced ga

✍ G. Giuliani; A. Falcone; A. Cirrincione; L. Garrison 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

721 ORAL Similar safety results of capec

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

3501 ORAL Capecitabine/cisplatin vs. con

✍ Y. Kang; W. Kang; D. Shin; J. Chen; J. Xiong; J. Wang; M. Lichinitser; M. Philco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB